A prospective open-label study to evaluate the effectiveness of intravenous ketamine as an adjunct in treating severe depression
Pavan Kumar Thatisetti Venkata,
Divya Bolla,
Raj Kiran Donthu
et al.
Abstract:Background
Ketamine, an emerging pharmacotherapeutic agent for depression, has demonstrated rapid and substantial improvement in mood and suicidal ideation, particularly in severe cases. While previous studies have established its efficacy, the current study aims to delve into the effectiveness of intravenous ketamine in treating severe depression.
Methods
An open-label prospective study enrolled 49 consecutive patients with severe depression. Base… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.